birb 796 has been researched along with purvalanol a in 2 studies
Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (purvalanol a) | Trials (purvalanol a) | Recent Studies (post-2010) (purvalanol a) |
---|---|---|---|---|---|
137 | 5 | 80 | 86 | 0 | 42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Cross, A; Edwards, SW; Glennon-Alty, L; Phoomvuthisarn, P; Wright, HL | 1 |
2 other study(ies) available for birb 796 and purvalanol a
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
The CDK inhibitor purvalanol A induces neutrophil apoptosis and increases the turnover rate of Mcl-1: potential role of p38-MAPK in regulation of Mcl-1 turnover.
Topics: Apoptosis; Cells, Cultured; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Healthy Volunteers; Humans; Monocytes; Myeloid Cell Leukemia Sequence 1 Protein; Naphthalenes; Neutrophils; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Purines; Pyrazoles; Signal Transduction | 2018 |